IRVINE, Calif.--(BUSINESS WIRE)--To support increasing demand globally for COVID-19 testing, BioDot has compressed production times for most new lateral flow dispensing platforms from months to four ...
Biodot, which started operations in 1994, manufactures automated ultra-low-volume fluid dispensing systems for labs that make antibody or serology tests. These tests are indicators of immune responses ...
Integration expands automated, ultra-low volume dispensing capabilities across point-of-care diagnostics, clinical diagnostics and the life sciences, positioning customers for further growth IRVINE, ...
BioDot Inc. of Irvine had plans to scale in 2020. It didn’t anticipate a global pandemic, which drove demand higher than ever before for its ultra low-volume dispensers that are used to dispense ...
The need for accessible, convenient and rapid testing over the course of the pandemic pushed the FDA to temporarily approve over-the-counter COVID-19 tests. That’s one result of the past year that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results